Treating Achondroplasia

Um blog dedicado ao tratamento da acondroplasia. A blog dedicated to the treatment of achondroplasia. Un blog dedicado al tratamiento de la acondroplasia.

Páginas

  • Home
  • Index (EN)
  • Index (PT)
  • Index (ES)
  • Referências / References
  • Support & Information
  • Research
  • Glossary (EN)
  • Glossário (PT)
  • Glosario (ES)

Monday, February 29, 2016

The Rare Disease Day 2016

http://www.rarediseaseday.org/





Posted by Morrys C. Kaisermann at 7:48 AM No comments:
Email ThisBlogThis!Share to TwitterShare to FacebookShare to Pinterest
Labels: Rare Disease Day
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)
"Knowing is not enough; we must apply.
Willing is not enough; we must do."
Goethe

“Be the change that you wish to see in the world.”
Gandhi

Translator - Choose your Language

Introdução - Introduction - Introducción

Este é um blog Português - Inglês - Espanhol cujo objetivo é divulgar o conhecimento atual e as linhas de pesquisa básica e pesquisa clínica para o tratamento farmacológico da acondroplasia.

This is a Portuguese - English - Spanish blog directed to divulge the current knowledge and the basic and clinical research towards pharmacological therapies for achondroplasia.

Este es un blog Portugués - Inglés - Español cuyo objetivo es difundir el conocimiento actual y las líneas de investigación básica e investigación clínica para el tratamiento farmacológico de la acondroplasia.

This is a shorter link for this blog.

  • Treating Achondroplasia

Visits

Search This Blog

Search Clinical Trials (US, EU, Australia)

  • ANZCTR Australia Clinical Trial Registry
  • ClinicalTrials.gov (US)
  • EU Clinical Trials register

Pesquisa PubMed - PubMed Query

  • PubMed

Publicações do Autor - Papers by the Author

  • Poster presented during the American Society of Human Genetics Meeting 2012, San Francisco, US (Nov 2012)
  • Letter to Journal of Bone and Joint Surgery (British volume), Mar 2012
  • Letter to Science TM, Oct 2011
  • Letter to the Journal Bone, Mar 2011

Investigadores - Investigators

  • Dr. Jeffrey Baron (US)
  • Dr. Frank Beier Lab (Canada)
  • Dr. Benoit de Crombrugghe Lab (US)
  • Dr. Janet E Henderson Lab (Canada)
  • Dr. Kalina Hristova Lab (US)
  • Dr. Pavel Krejci Lab (Czechia)
  • Dr. Henry Kronenberg Lab (US)
  • Dr. Laurence Legeai-Mallet (France)
  • Dr. Moosa Mohammadi Lab (US)
  • Dr. Efrat Monsonego Ornan Lab (Israel)
  • Dr. Geert Mortier - Growth Disorders (Belgium)
  • Dr. Sunichi Murakami (US)
  • Dr. Ola Nilsson Lab, Karolinska Institutet (Sweden)
  • Dr. David Ornitz Lab (US)
  • Dr. Ravi Savarirayan (Australia)
  • Dr. Ernestina Schipani Lab (US)
  • Dr. Joseph Schlessinger Lab (US)
  • Dr. Andrea Superti-Furga (Lausanne University, Switzerland)
  • Dr. Andrea Vortkamp Lab (Germany) (some pages in German)
  • Dr. William Wilcox Lab (US)
  • Dr. Andrew Wilkie Lab (UK)
  • Dr. Avner Yayon Lab - ProCore Biomed (Israel)

Links - Relevant information

  • Achondroplasia in Facebook
  • Fundación Alpe (Spain)
  • Growing Stronger (US)
  • The Chandler Project
  • Hospital Garrahan - Argentina
  • National Institutes of Health (US)
  • OCD - Displasias Esqueléticas Brasil
  • Serviços de Genética Médica no Brasil
  • Little People of America Medical Resources
  • Swedish Information Center for Rare Diseases

Popular Posts

  • Treating achondroplasia: where we are now
    A bit of the basics There have passed 20 years since the identification of the cause of achondroplasia. We now understand that achondropla...
  • CNP, the first potential pharmacological therapy for achondroplasia
    Under great expectations, parents and relatives of children bearing the fibroblast growth factor receptor 3 (FGFR3) mutation causing ...
  • Treating achondroplasia: thirty months with vosoritide
    News On October 18th, during the R&D Day (or Analyst Day) event held in New York, Biomarin released the 30 month follow up data from...
  • Stopping FGFR3 production to treat achondroplasia (part 1)
    Introduction This blog currently has 24 followers ( that's what Google tells me...). These resilient readers likely think I repeat th...
  • Treating achondroplasia: concepts and misconcepts about the potential therapies in development
    The first potential therapy to treat the bone growth arrest in achondroplasia, the C-type natriuretic peptide (CNP) analogue BMN-111, is rea...

Growing Stronger

Growing Stronger

Fundación Alpe

Fundación Alpe

OCD

OCD

Raríssimas

Raríssimas

RE(ACT)

RE(ACT)

Arquivo - Archive

  • ►  2022 (3)
    • ►  November (1)
    • ►  October (1)
    • ►  February (1)
  • ►  2021 (6)
    • ►  November (2)
    • ►  August (1)
    • ►  July (1)
    • ►  January (2)
  • ►  2020 (4)
    • ►  February (2)
    • ►  January (2)
  • ►  2019 (14)
    • ►  November (2)
    • ►  October (2)
    • ►  July (1)
    • ►  June (5)
    • ►  March (2)
    • ►  January (2)
  • ►  2018 (24)
    • ►  December (2)
    • ►  October (2)
    • ►  July (2)
    • ►  May (2)
    • ►  April (1)
    • ►  March (8)
    • ►  February (6)
    • ►  January (1)
  • ►  2017 (6)
    • ►  December (2)
    • ►  October (1)
    • ►  August (1)
    • ►  March (1)
    • ►  January (1)
  • ▼  2016 (23)
    • ►  December (1)
    • ►  October (4)
    • ►  September (2)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  April (3)
    • ►  March (3)
    • ▼  February (1)
      • The Rare Disease Day 2016
    • ►  January (6)
  • ►  2015 (36)
    • ►  November (3)
    • ►  October (2)
    • ►  September (1)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (6)
    • ►  April (1)
    • ►  March (5)
    • ►  January (6)
  • ►  2014 (37)
    • ►  December (6)
    • ►  November (1)
    • ►  August (3)
    • ►  July (2)
    • ►  June (3)
    • ►  May (3)
    • ►  March (3)
    • ►  February (6)
    • ►  January (10)
  • ►  2013 (80)
    • ►  December (8)
    • ►  November (4)
    • ►  October (6)
    • ►  September (21)
    • ►  July (5)
    • ►  June (4)
    • ►  May (8)
    • ►  April (4)
    • ►  March (1)
    • ►  February (4)
    • ►  January (15)
  • ►  2012 (104)
    • ►  December (6)
    • ►  November (11)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (8)
    • ►  June (8)
    • ►  May (17)
    • ►  April (1)
    • ►  March (3)
    • ►  February (17)
    • ►  January (11)

Quem sou eu

Morrys C. Kaisermann
Morrys C. Kaisermann, médico com especial interesse nas displasias ósseas associadas à mutações do FGFR3, das quais a ACONDROPLASIA é a forma mais comum.
View my complete profile

Who I am

Morrys Kaisermann, physician interested in the study of the FGFR3 related chondrodysplasias and specially in the most common presentation, ACHONDROPLASIA.

Tags

Acondroplasia (193) CNP (121) English (120) Português (113) Achondroplasia (110) BMN-111 (103) Español (100) Drug Development (87) Biomarin (84) Desenvolvimento de medicações (61) Desarollo de medicamentos (56) PTH (21) Growth plate (19) MK-4 (14) Decoy (12) CosmoB (9) OCD (3)

Followers
Morrys C Kaisermann, M.D., Ph.D.. Simple theme. Powered by Blogger.